NEUROENDOCRINE CARCINOMAS
Clinical trials for NEUROENDOCRINE CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets aggressive lung cancers
Disease control Recruiting nowThis study is testing a new drug called IDE849 for people with certain aggressive cancers, including small cell lung cancer, that have a specific marker called DLL3. The research aims to find safe doses and see if the drug can shrink tumors, either alone or combined with other me…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First patients sought for groundbreaking trial targeting rare, aggressive cancers
Disease control Recruiting nowThis is the first-ever study in people for a new drug called ADCT-701, designed for adults with rare and hard-to-treat cancers like neuroendocrine tumors and malignant peripheral nerve sheath tumors. The main goal is to find the safest and most effective dose by giving the drug t…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC